APOE4 Alzheimer's Gene Found to Weaken Bone Quality in Women

Scientists at the Buck Institute for Research on Aging and UC San Francisco have discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deficits specifically in female mice, with effects emerging as early as midlife. The research, published in Advanced Science, reveals an unexpected biological link between neurological and skeletal health, operating through a mechanism invisible to standard imaging techniques. The team identified a new molecular pathway that could eventually inform earlier diagnosis of cognitive decline and guide treatments for bone quality loss in women carrying the APOE4 gene variant.

APOE4 gene's sex-specific effects on bone quality

• ▪APOE4 is the most common genetic risk factor for Alzheimer's disease.
• ▪APOE4-related bone quality deficits in female mice can emerge as early as midlife.
• ▪APOE4 causes bone quality deficits specifically in female mice.

Research findings and detection challenges

• ▪Scientists at the Buck Institute for Research on Aging and collaborators at UC San Francisco discovered APOE4's effects on bone quality in female mice.
• ▪The findings on APOE4's effects on bone quality in female mice were published in Advanced Science.
• ▪The research findings reveal a biological link between Alzheimer's risk and skeletal health.
• ▪The research identified a new molecular pathway related to APOE4's effects on bone quality.
• ▪The APOE4-related bone quality deficits occur through a mechanism that is invisible to standard imaging.

Implications for Alzheimer's diagnosis and treatment

• ▪The newly identified molecular pathway related to APOE4 could guide treatment for bone quality loss in women who carry the APOE4 gene.
• ▪The newly identified molecular pathway related to APOE4 could one day inform earlier diagnosis of cognitive decline.

Perspective of Buck Institute and UC San Francisco researchers

• ▪The Buck Institute and UC San Francisco discovery reveals that APOE4's effects on bone quality operate through mechanisms invisible to standard imaging techniques.
• ▪The molecular pathway identified by Buck Institute and UC San Francisco researchers could guide future treatments for bone quality loss in women carrying APOE4.
• ▪The molecular pathway identified by Buck Institute and UC San Francisco researchers could enable earlier diagnosis of cognitive decline in APOE4 carriers.

Perspective of Women carrying the APOE4 gene variant

• ▪Women with APOE4 face skeletal health risks that current standard imaging methods cannot detect.
• ▪Women carrying APOE4 may experience bone quality deterioration as early as midlife due to the gene variant.

1 source